Ken Griffin Azenta, Inc. Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Azenta, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 80,000 shares of AZTA stock, worth $2.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

80,000

Previous 58,100 37.69%

Holding current value

$2.92 Million

Previous $2.81 Million 42.15%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$40.37 - $51.57 $6.2 Million - $7.92 Million	153,619 Added 388.92%	193,118 $9.66 Million
Q3 2024 Nov 14, 2024	SELL	$45.84 - $62.29 $16.7 Million - $22.8 Million	-365,256 Reduced 90.24%	39,499 $1.91 Million
Q2 2024 Aug 14, 2024	BUY	$50.27 - $59.04 $14.2 Million - $16.6 Million	281,599 Added 228.65%	404,755 $21.3 Million
Q1 2024 May 15, 2024	SELL	$57.82 - $67.51 $3.27 Million - $3.82 Million	-56,581 Reduced 31.48%	123,156 $7.42 Million
Q4 2023 Feb 14, 2024	BUY	$44.02 - $66.3 $2.16 Million - $3.26 Million	49,132 Added 37.62%	179,737 $11.7 Million
Q3 2023 Nov 14, 2023	SELL	$44.08 - $57.76 $10.7 Million - $14 Million	-242,316 Reduced 64.98%	130,605 $6.56 Million
Q2 2023 Aug 14, 2023	BUY	$36.45 - $46.68 $6.17 Million - $7.9 Million	169,334 Added 83.18%	372,921 $17.4 Million
Q1 2023 May 15, 2023	SELL	$39.51 - $61.95 $11.2 Million - $17.5 Million	-282,502 Reduced 58.12%	203,587 $9.08 Million
Q4 2022 Feb 14, 2023	BUY	$38.6 - $62.07 $18.8 Million - $30.2 Million	486,089 New	486,089 $28.3 Million
Q2 2022 Aug 15, 2022	SELL	$64.69 - $85.07 $3.35 Million - $4.4 Million	-51,760 Reduced 79.66%	13,220 $953,000
Q1 2022 May 16, 2022	SELL	$76.3 - $103.81 $11.5 Million - $15.7 Million	-151,368 Reduced 69.97%	64,980 $5.39 Million
Q4 2021 Feb 14, 2022	BUY	$92.98 - $124.15 $2.02 Million - $2.7 Million	21,744 Added 11.17%	216,348 $22.3 Million
Q3 2021 Nov 15, 2021	SELL	$77.49 - $109.17 $15.2 Million - $21.5 Million	-196,622 Reduced 50.26%	194,604 $19.9 Million
Q2 2021 Aug 16, 2021	BUY	$86.59 - $107.47 $18.9 Million - $23.4 Million	218,075 Added 125.94%	391,226 $37.3 Million
Q1 2021 May 17, 2021	BUY	$66.32 - $90.93 $4.45 Million - $6.1 Million	67,103 Added 63.28%	173,151 $14.1 Million
Q4 2020 Feb 16, 2021	BUY	$46.7 - $75.22 $4.61 Million - $7.42 Million	98,612 Added 1326.14%	106,048 $7.2 Million
Q3 2020 Nov 16, 2020	SELL	$42.77 - $56.69 $11.6 Million - $15.4 Million	-270,826 Reduced 97.33%	7,436 $344,000
Q1 2020 May 15, 2020	SELL	$22.69 - $44.14 $4.33 Million - $8.43 Million	-190,967 Reduced 40.7%	278,262 $8.49 Million
Q4 2019 Feb 14, 2020	BUY	$35.49 - $48.05 $15 Million - $20.3 Million	421,633 Added 885.86%	469,229 $19.7 Million
Q3 2019 Nov 14, 2019	BUY	$30.18 - $41.75 $811,751 - $1.12 Million	26,897 Added 129.94%	47,596 $1.76 Million
Q2 2019 Aug 14, 2019	BUY	$29.53 - $41.1 $271,912 - $378,448	9,208 Added 80.13%	20,699 $802,000
Q1 2019 May 15, 2019	BUY	$24.38 - $33.75 $87,889 - $121,668	3,605 Added 45.71%	11,491 $0
Q4 2018 Feb 14, 2019	SELL	$23.22 - $35.29 $579,106 - $880,132	-24,940 Reduced 75.98%	7,886 $206,000
Q3 2018 Nov 13, 2018	BUY	$28.71 - $39.6 $606,843 - $837,025	21,137 Added 180.83%	32,826 $0
Q2 2018 Aug 10, 2018	SELL	$24.88 - $36.36 $661,733 - $967,066	-26,597 Reduced 69.47%	11,689 $0
Q1 2018 May 11, 2018	SELL	$23.3 - $30.15 $1.77 Million - $2.29 Million	-76,117 Reduced 66.53%	38,286 $1.04 Million
Q4 2017 Feb 09, 2018	SELL	$22.54 - $34.39 $5.33 Million - $8.13 Million	-236,387 Reduced 67.39%	114,403 $2.73 Million
Q3 2017 Nov 09, 2017	BUY	$22.6 - $30.36 $7.93 Million - $10.6 Million	350,790	350,790 $10.7 Million

Others Institutions Holding AZTA

# of Institutions

337

Shares Held

51.4M

Call Options Held

237K

Put Options Held

302K

View Full List

About Azenta, Inc.

Ticker AZTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 75,020,400
Market Cap $2.74B
Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...

More about AZTA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account